An alternative strategy to WT p53 gene therapy is re-engineered p53 therapy, including attaching mitochondrial targeting signals (MTS) to full length p53 and p53 subdomains such as the DNA-binding domain for the rapid (but transient) induction of apoptosis in cancer cells. The gene discussed is TP53; the disease is cancer.